Actuate Therapeutics, Inc. (ACTU)

NASDAQ: ACTU · Real-Time Price · USD

7.99

-0.24 (-2.92%)

Apr 17, 2025, 4:00 PM EDT - Market closed

Actuate Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-27.29	-24.74	-20.16
Stock-Based Compensation	2	0.42	0.65
Other Operating Activities	2.35	0.12	-0.02
Change in Accounts Payable	-1.5	1.29	0.59
Change in Other Net Operating Assets	2.6	1.28	1.15
Operating Cash Flow	-21.84	-21.63	-17.79
Short-Term Debt Issued	5.7	-	-
Total Debt Issued	5.7	-	-
Short-Term Debt Repaid	-0.2	-	-
Total Debt Repaid	-0.2	-	-
Net Debt Issued (Repaid)	5.5	-	-
Issuance of Common Stock	23.96	-	-
Other Financing Activities	-1.93	-	-
Financing Cash Flow	27.53	4.13	19.26
Net Cash Flow	5.68	-17.49	1.46
Levered Free Cash Flow	-12.39	-12.64	-
Unlevered Free Cash Flow	-12.38	-12.61	-
Change in Net Working Capital	-1.35	-2.57	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q